Bioorganic and Medicinal Chemistry Letters p. 2691 - 2696 (2001)
Update date:2022-08-05
Topics:
Barrow, James C
Nantermet, Philippe G
Selnick, Harold G
Glass, Kristen L
Ngo, Phung L
Young, Mary Beth
Pellicore, Janetta M
Breslin, Michael J
Hutchinson, John H
Freidinger, Roger M
Condra, Cindra
Karczewski, Jerzy
Bednar, Rodney A
Gaul, Stanley L
Stern, Andrew
Gould, Robert
Connolly, Thomas M
Thrombin is the most potent agonist of platelet activation, and its effects are predominantly mediated by platelet thrombin receptors. Therefore, antagonists of the thrombin receptor have potential utility for the treatment of thrombotic disorders. Screening of combinatorial libraries revealed 2 to be a potent antagonist of the thrombin receptor. Modifications of this structure produced 11k, which inhibits thrombin receptor stimulated secretion and aggregation of platelets.
View MoreJinhua Haoyuan Chemical CO., LTD(expird)
Contact:86-579-82465583
Address:Jinhua,Zhejiang
Chengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Shanghai Bocimed Pharmaceutical Co., Ltd.
website:http://www.bocimed.com
Contact:+86-21-68861632
Address:Building 1, Lane 647, Songtao Road, Zhangjiang High-Tech Park, Shanghai
Tianjin SPHINX SCIENTIFIC LAB.
Contact:+86-022-66211289
Address:Tianda high-tech Park. No.80,the 4th Avenue
Nanjing Vincero International Trading Co.,Ltd
Contact:8618936897229
Address:NO.68, ZhuShan Road, JiangNing WanDa Plaza, Building E Room 1703
Doi:10.1016/S0008-6215(00)90386-0
(1986)Doi:10.1021/acs.joc.1c01090
(2021)Doi:10.1021/jo00952a042
(1973)Doi:10.3390/molecules23081859
(2018)Doi:10.1021/ol0167614
(2001)Doi:10.1039/c5cc04009d
(2015)